Related Experiment Video
Updated: Jun 3, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
[Nephroprotection and vascular risk: prevention of renal damage in hypertension]
1Servicio de Nefrología, Fundación Althaia, Manresa, Universitat Internacional de Catalunya, Barcelona, Spain. jgalceran@althaia.cat
Insights
Hypertension management is crucial for kidney health. This review examines blood pressure targets and renin-angiotensin system blockers for patients with hypertension but without diabetes or proteinuria, offering renal preservation recommendations.
Area of Science:
- Nephrology
- Cardiology
- Hypertension Management
Context:
- Kidney dysfunction is common, especially in hypertensive individuals, increasing risks for end-stage renal disease and cardiovascular events.
- Current chronic kidney disease guidelines advocate strict blood pressure control (<130/80 mmHg) and renin-angiotensin system blockers.
- Evidence supporting these guidelines for hypertensive patients without diabetes or proteinuria is limited.
Purpose:
- To review the controversy surrounding current hypertension management guidelines for renal preservation.
- To evaluate the efficacy of ambitious blood pressure control and renin-angiotensin system blockers in hypertensive patients without diabetes or proteinuria.
- To provide evidence-based recommendations for optimizing renal protection in this patient group.
Summary:
- The article critically analyzes the existing evidence for intensive blood pressure management (<130/80 mmHg) and renin-angiotensin system blockers in hypertensive patients without diabetes or proteinuria.
- It highlights the scarcity of data supporting these interventions in this specific population.
- The review synthesizes current knowledge to address the controversy and inform clinical practice.
Impact:
- Offers clarity on the application of hypertension guidelines for kidney protection in a frequently encountered clinical scenario.
- Aims to guide clinicians in making informed decisions for renal preservation in hypertensive patients lacking diabetes or proteinuria.
- Contributes to reducing cardiovascular morbidity and mortality associated with kidney dysfunction in hypertensive individuals.
Abstract:
Kidney dysfunction is highly prevalent in the general population and even more so among patients with hypertension, leading to a high risk not only of progression to end-stage renal insufficiency but also of greater cardiovascular morbidity and mortality. Clinical guidelines for chronic kidney disease recommend ambitious blood pressure control (< 130/80 mmHg or lower if there is proteinuria) and the use of renin-angiotensin system blockers. However, the evidence for these recommendations in patients with hypertension without diabetes or proteinuria is scarce. The present article reviews this controversy and concludes with recommendations for better renal preservation in patients with hypertension.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury VI: Nursing Management
Diabetic Nephropathy
Antihypertensive Drugs: Action of Diuretics
Hypertension and Regulation of Blood Pressure
Chronic Kidney Disease III: Interprofessional Care
